Parsons Helen M, Harlan Linda C, Schmidt Susanne, Keegan Theresa H M, Lynch Charles F, Kent Erin E, Wu Xiao-Cheng, Schwartz Stephen M, Chu Roland L, Keel Gretchen, Smith Ashley Wilder
Department of Epidemiology and Biostatistics, The University of Texas Health Science Center , San Antonio, Texas.
Applied Research Program, National Cancer Institute , Bethesda, Maryland.
J Adolesc Young Adult Oncol. 2015 Sep;4(3):141-50. doi: 10.1089/jayao.2014.0041.
Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited.
Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests.
Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01).
Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.
医生在为青少年和青年(AYA)癌症患者提供有效治疗以及助力其成功过渡到癌症生存阶段方面发挥着关键作用。然而,由于缺乏针对AYA癌症的医学专科,关于患有癌症的AYA患者的治疗地点及治疗医生的信息有限。
利用美国国立癌症研究所基于人群的AYA HOPE研究,确定了903名医生治疗的464名确诊时年龄在15 - 39岁的AYA患者。使用卡方检验,按确诊年龄和癌症类型(生殖细胞癌、非霍奇金淋巴瘤、霍奇金淋巴瘤、急性淋巴细胞白血病[ALL]和肉瘤)检查医生和医院特征的差异。
治疗医生大多年龄在51 - 64岁之间,为男性,在美国接受非儿科专科培训,且在大都市地区的团体诊所工作。年龄较大的患者较少由儿科医生治疗(p < 0.01),而更有可能由在美国接受培训、无研究/教学职责的医生治疗,且治疗医院没有住院医师培训项目(p < 0.05)。少数儿科医生(n = 44)中的大多数治疗ALL患者。与其他癌症类型相比,有研究/教学职责的医生以及医学院的医生更有可能治疗ALL和肉瘤患者(p < 0.01)。HL患者中,73%在癌症中心接受治疗,而生殖细胞癌患者为56%(p < 0.01),而ALL(85%)和肉瘤(87%)患者更有可能在有住院医师培训项目的医院接受治疗(p < 0.01)。
大多数患有癌症的AYA患者由社区环境中的非儿科医生治疗,尽管医生特征因患者癌症类型和确诊年龄而有显著差异。